Insights

Insights


Latest News

    Trending Topics

      Futures

      Products


      Brand Protection

      IP Intelligence

      Litigation Analysis

      Case Management

      Nunc Orci


      Products Case Studies

      People

      Careers

      About

      Announcements

      • About Us
      • The Rouse Network
      • The Rouse Difference
      • Rouse Connect

      Grass Roots

      • Climate Change
      • Mitrataa
      • Rouse Cares

      ClientWEB

      Thank You

      Your are now register subscriber for our Rouse

      Medtech & Financing

      Published on 28 Aug 2020 | 1 minute read

      Fund raising to enable development and launch of breast cancer detection wearable device

      Overview

      A technology scale-up wanted to secure investment and product development partnerships in China for their wearable breast cancer detection device.

      Our Approach

      With the product six months from launch, we identified product and distribution partners and developed their pitch for Chinese investment. We also structured Hong Kong and Irish based entities to specifically support market entry. Working in partnership with Southern Capital Partners, a boutique investment advisory firm, we used our networks and understanding of the Chinese market to identify and target investors.

       

      ​Value Created

      Our client raised USD$3.8 million in pre-A round funding, with the round led by iFlytek, one of China’s leading artificial intelligence companies. As a result, product development was concluded and the product launched in Hong Kong in 2018, with further series A funding planned for China and ASEAN expansion.

       

      30% Complete
      Principal, Head of Global Consultancy
      +44 20 7536 4103
      Principal, Rouse Consultancy
      +44 20 7536 4107
      Principal, Head of Global Consultancy
      +44 20 7536 4103
      Principal, Rouse Consultancy
      +44 20 7536 4107